...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine?
【24h】

Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine?

机译:Delta心肌肌钙蛋白的实际应用价值:我们准备好绝对推进临床常规了吗?

获取原文
           

摘要

The improved analytical characteristics of both sensitive and high-sensitivity assays for cardiac troponins I (cTnI)3 and T (cTnT) have substantially increased the diagnostic sensitivity for early detection of acute myocardial infarction (AMI) (1–3). With the ability to detect small increases in circulating cardiac troponins, any cause of myocardial injury will now produce a substantially greater number of analytically true positive findings not detectable by earlier generations of cardiac troponin assays (3–6). This evolution has led to a decrease in diagnostic specificity for the diagnosis of AMI, a concern to many clinicians who may incorrectly equate any increased cardiac troponin value to an AMI (7, 8). Observational studies, although conducted predominately with prior-generation assays, have consistently demonstrated that any increase in cardiac troponin due to almost any mechanism of myocardial injury carries an association with worse outcomes (3, 7). Nevertheless, because diagnostic specificity is pivotal to appropriate therapy, pragmatic approaches are needed to sustain diagnostic specificity with sensitive and high-sensitivity assays for cardiac troponin. In this issue of Clinical Chemistry , Mueller and colleagues (9) report on their experience with one such approach that uses the change in cardiac troponin over time (δ).First proposed by Fesmire in 2000 (10), diagnostic algorithms based on the δ cardiac troponin have now been shown in several studies to improve diagnostic specificity, but not necessarily diagnostic sensitivity (11–13). When a sensitive contemporary assay (Ortho Clinical Diagnostics Vitros ES cTnI) was used, a 6-h δ based on an optimized 30% change improved diagnostic specificity from 77% to 91%, whereas diagnostic sensitivity changed from 94% based on the 99th-percentile value, compared with 75% based on the δ value (11). More recently, using the high-sensitivity cTnT assay (hs-cTnT), Reichlin and coworkers observed that a criterion of an absolute …
机译:心肌肌钙蛋白I(cTnI)3和T(cTnT)的灵敏和高灵敏测定方法的分析特性均得到改善,从而大大提高了对急性心肌梗死(AMI)的早期检测的诊断敏感性(1-3)。由于能够检测到循环中心肌肌钙蛋白的微小增加,因此任何原因的心肌损伤现在都将产生大量的分析真实阳性结果,而早期的心肌肌钙蛋白测定法则无法检测到这些结果(3-6)。这种演变导致对AMI诊断的诊断特异性降低,这是许多临床医生所担心的,他们可能错误地将任何心肌肌钙蛋白值等同于AMI(7,8)。观察性研究尽管主要是在前代试验中进行的,但始终如一地证明,由于几乎任何心肌损伤机制而导致的心肌肌钙蛋白升高都会导致预后不良(3、7)。然而,由于诊断特异性对于适当的治疗至关重要,因此需要务实的方法来通过对心肌肌钙蛋白的敏感和高敏感性测定来维持诊断特异性。在本期《临床化学》中,Mueller及其同事(9)报告了他们使用这种方法的经验,该方法利用了心肌肌钙蛋白随时间(δ)的变化.Fesmire于2000年首次提出(10),该诊断算法基于δ现已在多项研究中显示了心肌肌钙蛋白可提高诊断特异性,但不一定能提高诊断敏感性(11-13)。当使用灵敏的当代测定法(Ortho Clinical Diagnostics Vitros ES cTnI)时,基于优化的30%的6小时δ变化将诊断特异性从77%提高到91%,而诊断灵敏度从94%改变为99%。百分比值,而基于δ值的百分比为75%(11)。最近,Reichlin及其同事使用高灵敏度cTnT分析(hs-cTnT)观察到了绝对…的标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号